Clinical and cost outcomes following genomics‐informed treatment for advanced cancers

BACKGROUND: Single‐arm trials are common in precision oncology. Owing to the lack of randomized counterfactual, resultant data are not amenable to comparative outcomes analyses. Difference‐in‐difference (DID) methods present an opportunity to generate causal estimates of time‐varying treatment outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Weymann, Deirdre, Pollard, Samantha, Chan, Brandon, Titmuss, Emma, Bohm, Alexandra, Laskin, Janessa, Jones, Steven J. M., Pleasance, Erin, Nelson, Jessica, Fok, Alexandra, Lim, Howard, Karsan, Aly, Renouf, Daniel J., Schrader, Kasmintan A., Sun, Sophie, Yip, Stephen, Schaeffer, David F., Marra, Marco A., Regier, Dean A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335838/
https://www.ncbi.nlm.nih.gov/pubmed/34152087
http://dx.doi.org/10.1002/cam4.4076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335838/
https://www.ncbi.nlm.nih.gov/pubmed/34152087
http://dx.doi.org/10.1002/cam4.4076

Ejemplares similares